At the same time, some studies have shown that breast cancer patients with negative ER before NAC and high expression of Ki67 are more sensitive to chemotherapy and benefit more after chemotherapy, and the two may be sensitive factors for predicting the efficacy of chemotherapy [24, 25]. The gene discussed is MKI67; the disease is breast carcinoma.